Table 3.
Comparison of biochemical and clinical characteristics at baseline and after each course of treatment.
| Baseline Condition | One Course | Two Course | Three Course | P | |
|---|---|---|---|---|---|
| Number | 31 | 31 | 21 | 16 | — |
| Hb (g/L)a | 111.32 ± 21.14 | 105.97 ± 18.61 | 105.95 ± 24.07 | 112.63 ± 22.17 | 0.598 |
| WBC (*109/L)a | 7.96 ± 3.23 | 7.25 ± 2.91 | 7.75 ± 3.02 | 7.21 ± 1.57 | 0.736 |
| CRP (mg/L)b | 2.53 (1.51,6.29) | 2.67 (0.82,5.78) | 4.27 (1.93,18.66) | 3.96 (1.81,11.62) | 0.423 |
| PCT (ng/ml)b | 0.29 (0.17,0.68) | 0.28 (0.13,0.53) | 0.56 (0.23,0.85) | 0.32 (0.22,1.25) | 0.414 |
| ALB (g/L)a | 38.14 ± 5.41 | 38.36 ± 5.09 | 37.33 ± 6.39 | 39.63 ± 8.06 | 0.719 |
| ALP (U/L)b | 111 (80,185) | 100 (80,196) | 145 (99,252.5) | 124 (88,176) | 0.37 |
| Ca (mmol/L)a | 2.31 ± 0.28 | 2.22 ± 0.27 | 2.23 ± 0.31 | 2.23 ± 0.25 | 0.587 |
| P (mmol/l)a | 1.93 ± 0.60 | 1.59 ± 0.67 | 1.54 ± 0.49 | 1.36 ± 0.48 | 0.009 |
| PTH (pg/mL)b | 399.7 (114.5,903.5） | 266.7 (101.8,651.7) | 392.9 (58.5,573.4) | 411.9 (51.3,846.0) | 0.626 |
| NPRSb | 5 (0,7) | 2 (0,3) | 0 (0,3) | 0 (0,1.5） | 0.001 |
Superscript a: means that testing correlation between the index and baseline condition by one-way ANOVA test.
Superscript b: means that testing correlation between the index and baseline condition by Kruskal-Wallis test.
NPRS means numerical pain rating scale (range: 1–10).
P-values are shown here for comparison and categories of column proportion differ significantly from each other at the 0.05 level.
Normal reference ranges: Hb: 130–175 g/L,WBC: 3.5–9.5*109/L, CRP: 0–3.0 mg/L, PCT: 0–0.5 ng/ml, ALB: 40–55 g/L, ALP: 45–125 U/L, Ca: 2.11–2.52 mmol/L, P:0.85–1.51 mmol/l, PTH:12–88 pg/ml.